Product
Pegylated G-CSF
3 clinical trials
12 indications
Indication
Pancreatic CancerIndication
Germ Cell TumorIndication
TeratomaIndication
ChoriocarcinomaIndication
GerminomaIndication
Mixed Germ Cell TumorIndication
yolk sac tumorIndication
Malignant Germ Cell NeoplasmIndication
Extragonadal SeminomaIndication
Nonseminomatous Germ Cell TumorIndication
Testicular seminomaClinical trial
A Phase III, Double-Blind, Randomised, Placebo-Controlled Study to Assess the Efficacy and Safety of Selumetinib (AZD6244; ARRY-142886) (Hyd-Sulfate) in Combination With Docetaxel, in Patients Receiving Second Line Treatment for KRAS Mutation-Positive Locally Advanced or Metastatic Non Small Cell Lung Cancer (Stage IIIB - IV) (SELECT 1)Status: Active (not recruiting), Estimated PCD: 2016-06-07
Clinical trial
NEO-adjuvant Chemo-Immunotherapy in Pancreatic CancerStatus: Recruiting, Estimated PCD: 2024-06-01
Clinical trial
A Randomized Phase III Trial Comparing Conventional-Dose Chemotherapy Using Paclitaxel, Ifosfamide, and Cisplatin (TIP) With High-Dose Chemotherapy Using Mobilizing Paclitaxel Plus Ifosfamide Followed by High-Dose Carboplatin and Etoposide (TI-CE) as First Salvage Treatment in Relapsed or Refractory Germ Cell TumorsStatus: Active (not recruiting), Estimated PCD: 2024-06-01